Press Releases

All Releases
View Summary Myriad RBM Announces the Launch of OncologyMAP® v. 2.0
May 9, 2012
PDF 16.3 KB Add to Briefcase
View Summary Myriad Genetics Reports Record Third Fiscal Quarter 2012 Results
May 1, 2012
PDF 25.4 KB Add to Briefcase
View Summary Myriad Genetics to Announce Fiscal 2012 Third Quarter Results on Tuesday, May 1, 2012
Apr 10, 2012
PDF 12.2 KB Add to Briefcase
View Summary Myriad Study Finds High Prevalence of Mutations in the PMS2 Gene
Mar 29, 2012
PDF 15.3 KB Add to Briefcase
View Summary Myriad and Cephalon Enter Into Companion Diagnostic Agreement
Mar 28, 2012
PDF 15.6 KB Add to Briefcase
View Summary Supreme Court of the United States Remands Gene Patenting Case
Mar 26, 2012
PDF 17.5 KB Add to Briefcase
View Summary Prolaris(R) Test Awarded Best Poster Honor at 27th Annual EAU Congress in Paris, France
Feb 27, 2012
PDF 16.2 KB Add to Briefcase
View Summary Myriad's Prolaris(R) Test Shown to Significantly Predict Prostate Cancer Outcome in Needle Biopsy Tissue
Feb 24, 2012
PDF 15.5 KB Add to Briefcase
View Summary Myriad Genetics to Present at the Cowen and Company 32nd Annual Health Care Conference
Feb 22, 2012
PDF 11.7 KB Add to Briefcase
View Summary Myriad Genetics to Present at the Leerink Swann 2012 Global Healthcare Conference
Feb 6, 2012
PDF 11.6 KB Add to Briefcase
View Summary Myriad's Prolaris(R) Test Shown to Significantly Predict Biochemical Recurrence Risk After Prostatectomy
Feb 2, 2012
PDF 15.7 KB Add to Briefcase
View Summary Myriad Genetics Reports Second Quarter Fiscal Year 2012 Results
Jan 31, 2012
PDF 24.1 KB Add to Briefcase
View Summary Myriad Genetics Acquires Exclusive Rights to RAD51C Gene
Jan 18, 2012
PDF 15.7 KB Add to Briefcase
View Summary Myriad Genetics to Announce Fiscal 2012 Second Quarter Results on Tuesday, January 31, 2012
Jan 17, 2012
PDF 12.2 KB Add to Briefcase
View Summary Myriad Genetics to Present at the 30th Annual J.P. Morgan Healthcare Conference
Dec 28, 2011
PDF 11.6 KB Add to Briefcase
View Summary Myriad Genetics Presents BRACAnalysis(R) Cost-Effectiveness Study at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium
Dec 9, 2011
PDF 17.0 KB Add to Briefcase
View Summary Myriad Genetics to Present at the 22nd Annual Oppenheimer Healthcare Conference
Dec 1, 2011
PDF 14.2 KB Add to Briefcase
View Summary Myriad Genetics to Attend the 23rd Annual Piper Jaffray Health Care Conference
Nov 21, 2011
PDF 13.7 KB Add to Briefcase
View Summary Myriad Genetics Receives the "Corporate Spirit of Giving Award" From the Utah Philanthropy Day Committee
Nov 2, 2011
PDF 13.9 KB Add to Briefcase
View Summary Myriad Genetics Reports First Quarter Fiscal Year 2012 Results
Nov 1, 2011
PDF 22.1 KB Add to Briefcase
Showing 81-100 of 294 Page: 1 2 3 4 5 6 7 8 9 ... 15  Previous 20 | Next 20
Add to Briefcase = add release to Briefcase

Stock Quote (NASDAQ:MYGN)

Price:
39.40
Change:
+ 1.24
Open:
38.21
Previous Close:
38.16
Day High:
39.54
Day Low:
38.21
52 Week High:
42.50
52 Week Low:
20.02
Volume:
1,520,000
4:00 PM ET on Apr 22, 2014
Delayed at least 20 minutes.
Provided by eSignal.

Investor Contact

Scott Gleason
(801) 584-1143
sgleason@myriad.com

Media Contact

Ron Rogers
Corporate Communications and Media Relations
(801) 584-3065
rrogers@myriad.com